bell
The current prices are delayed by 15 mins, login to check live prices.
Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd

(SPARC)

₹201.29▲1.03%

as on 04:01PM, 24 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Sun Pharma Advanced Research Company Ltd Performance

  • Day's Low

    Day's High

    ₹200.12
    Day's Price Range
    ₹205.04

  • 52 Week's Low

    52 Week's High

    ₹189.75
    52-Week Price Range
    ₹472.8
1 Month Return-0.45 %
3 Month Return-6.92 %
1 Year Return-22.15 %
Previous Close₹203.38
Open₹204.82
Volume5.81L
Upper Circuit-
Lower Circuit-
Market Cap₹6,532.30Cr

Sun Pharma Advanced Research Company Ltd Key Statistics

P/E Ratio-15.98
PEG Ratio3.59
Market Cap₹6,532.30 Cr
P/B Ratio96.09
EPS-11.93
Dividend Yield0
SectorPharmaceuticals
ROE0

Sun Pharma Advanced Research Company Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹6,532.30 Cr5.83%0.79-₹388 Cr₹75 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹28,426.00 Cr112.52%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹17,481.58 Cr28.58%0.57₹72 Cr₹6,702 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹15,623.72 Cr48.35%0.68₹218 Cr₹1,296 Cr
Poly Medicure Ltd
Poly Medicure Ltd
BUY₹25,627.30 Cr219.91%0.55₹258 Cr₹1,375 Cr
See all

Sun Pharma Advanced Research Company Ltd Mutual Fund Holdings

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Share Price: ₹201.29 per share as on 24 Dec, 2024 04:01 PM
Market Capitalisation: ₹6,532.30Cr as of today
Revenue: ₹12.86Cr as on September 2024 (Q3 24)
Net Profit: ₹-107.33Cr as on September 2024 (Q3 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Signs LOI for Oncology Asset Licensing - 17 Dec, 2024

    Sun Pharma Advanced Research Company has signed a binding Letter of Intent with UCSF and Tiller Therapeutics to license a pre-clinical oncology asset, securing a 55% equity stake in Tiller. The agreement aims to advance treatment for solid tumors, addressing a significant medical need.

  • Sparc Electrex Reports Mixed Financial Results - 26 Nov, 2024

    Sparc Electrex reported a 39.72% increase in net sales to Rs 1.34 crore for September 2024, but net profit fell 76.08% to Rs 0.02 crore. EBITDA also declined by 50%. The stock has seen significant losses, with -27.81% returns over the last 6 months and -44.33% over the last year.

  • Sun Pharma Advanced Research Sees Surge in Volume - 22 Nov, 2024

    On November 22, 2024, Sun Pharma Advanced Research Company Ltd experienced a significant volume increase, reaching 40.83 lakh shares, 13.33 times the two-week average. The stock rose by 8.35% to Rs. 206.23.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.51% to 31.95% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.08% to 0.10% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 49.7% return, outperforming this stock by 71.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.1% return, outperforming this stock by 148.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SPARC stock has moved down by -7.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.64% to 2.15% in Sep 2024 quarter

Sun Pharma Advanced Research Company Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹21.18Cr (-)₹13.86Cr (↓34.56%)₹16.56Cr (↑19.48%)₹16.81Cr (↑1.51%)₹12.86Cr (↓23.50%)
Net Income-₹86.42Cr (-)-₹99.65Cr (↑15.31%)-₹105.79Cr (↑6.16%)-₹95.90Cr (↓9.35%)-₹107.33Cr (↑11.92%)
Net Profit Margin-408.03% (-)-718.98% (↑76.21%)-638.83% (↓11.15%)-570.49% (↓10.70%)-834.60% (↑46.30%)
Value in ₹ crore
Details2021202220232024
Total Assets₹229.70Cr (-)₹280.08Cr (↑21.93%)₹830.12Cr (↑196.39%)₹486.34Cr (↓41.41%)
Total Liabilities₹397.95Cr (-)₹248.85Cr (↓37.47%)₹317.35Cr (↑27.53%)₹361.49Cr (↑13.91%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹210.81Cr (-)-₹151.90Cr (↓27.94%)-₹208.23Cr (↑37.08%)-₹69.12Cr (↓66.81%)-₹429.43Cr (↑521.28%)

Index Inclusions

BSE Healthcare

₹44,092.04

0.03 (▲13.51%)

S&P BSE 400 MidSmallCap

₹12,114.59

0.17 (▲20.14%)

BSE Small-Cap

₹55,023.17

0.37 (▲205.26%)

Nifty 500

₹22,402.70

-0.04 (▲-9.6%)

BSE 500

₹35,222.65

-0.02 (▲-8.79%)

Nifty MidSmallcap 400

₹19,908.90

0.13 (▲24.95%)

S&P BSE 250 SmallCap

₹7,053.13

0.37 (▲25.99%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Nifty Smallcap 250

₹17,672.45

0.31 (▲54.35%)

Sun Pharma Advanced Research Company Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
2.15%
-18.64
Mutual Funds
0.1%
30.68
Retail Investors
31.95%
1.41
Others
0.12%
21.83

Sun Pharma Advanced Research Company Ltd Key Indicators

Details2024
Return On Assets %-79.62
Details2024
Book Value Per Share (₹)3.88
Details2024
Earning Per Share (₹)-11.93

Sun Pharma Advanced Research Company Ltd Valuation

Sun Pharma Advanced Research Company Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-15.98x)

December 24, 2024

Industry (56.56x)

December 24, 2024

Highest (0.00x)

December 29, 2023

LowHigh

Sun Pharma Advanced Research Company Ltd Earnings and Dividends

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit fell -24.2% since last year same period to ₹-107.33Cr in the Q2 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -11.92% fall in its net profits since last 3-months.

    Read More about Earnings Results

Sun Pharma Advanced Research Company Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sun Pharma Advanced Research Company Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Sun Pharma Advanced Research Company Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares.

Sun Pharma Advanced Research Company Ltd (SPARC) share price today is ₹201.29

Sun Pharma Advanced Research Company Ltd is listed on NSE

Sun Pharma Advanced Research Company Ltd is listed on BSE

  • Today’s highest price of Sun Pharma Advanced Research Company Ltd is ₹205.04.
  • Today’s lowest price of Sun Pharma Advanced Research Company Ltd is ₹200.12.

PE Ratio of Sun Pharma Advanced Research Company Ltd is -15.98

PE ratio = Sun Pharma Advanced Research Company Ltd Market price per share / Sun Pharma Advanced Research Company Ltd Earnings per share

Today’s traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 5.81L.

Today’s market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹6532.3Cr.

Sun Pharma Advanced Research Company Ltd(SPARCPrice
52 Week High
₹472.8
52 Week Low
₹189.75

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹201.29. It is down -57.43% from its 52 Week High price of ₹472.8

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹201.29. It is up 6.08% from its 52 Week Low price of ₹189.75

Sun Pharma Advanced Research Company Ltd(SPARCReturns
1 Day Returns
-2.09%
1 Month Returns
-0.45%
3 Month Returns
-6.92%
1 Year Returns
-22.15%